Russell Investments Group
INSY

Russell Investments Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Russell Investments Group’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,199
Closed -$55K – 3101
2017
Q1 		$55K Hold
5,199
– – ﹤0.01% 2892
2016
Q4 		$48K Buy
+5,199
New +$58.7K ﹤0.01% 2981

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Russell Investments Group's INSY Position: Q2 2017 in Review

Russell Investments Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2017, closing a stake of 5,199 shares — an estimated $55K sold.

Russell Investments Group first reported a position in INSY in Q4 2016 and held it in 2 quarters. The position peaked at $55K in Q1 2017. 118 funds tracked by Wall St. Rank hold INSY as of Q2 2017.

  • Russell Investments Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Russell Investments Group sold 5,199 Insys Therapeutics, Inc. shares in Q2 2017, an estimated $55K.
  • Russell Investments Group first reported a position in Insys Therapeutics, Inc. in Q4 2016 and held it in 2 quarters.
  • Russell Investments Group's Insys Therapeutics, Inc. position peaked at $55K in Q1 2017.
  • 118 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2017.

Based on Russell Investments Group's 13F filing for Q2 2017, filed 25 Jul 2017.